𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ovarian vein thrombosis in the antiphospholipid syndrome

✍ Scribed by Marc André; Isabelle Delèvaux; Zahir Amoura; Pierre Corbi; Christophe Courthaliac; Olivier Aumaître; Jean-Charles Piette


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
102 KB
Volume
50
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Ovarian vein thrombosis (OVT) is an unusual condition mainly observed during the postpartum period. It has not been reported to date in the antiphospholipid syndrome. Two female patients with definite antiphospholipid syndrome, ages 33 years and 73 years, were diagnosed as having OVT by computed tomography (CT) scan, according to the radiologic criteria described by Zerhouni et al. In 1 of the women, the left vein was affected by OVT, while in the other woman, the right vein was affected. One of the patients had a pulmonary embolism; the diagnosis of OVT was established after she underwent a cesarean section and a right atrium thrombectomy. The other patient had no vascular manifestations. OVT was asymptomatic in both patients. Searches for associated thrombophilic states yielded negative results. With the continuation of anticoagulation therapy, the 2 patients have remained in good condition. Resolution of the OVT was observed in the patient who underwent a CT scan during followup. To our knowledge, this is the first report of OVT occurring in the antiphospholipid syndrome. Given that it may develop in the absence of pelvic clinical manifestations, this complication may be underdiagnosed.


📜 SIMILAR VOLUMES


Antiphospholipid syndrome and recurrent
✍ Berkun, Y. ;Padeh, S. ;Barash, J. ;Uziel, Y. ;Harel, L. ;Mukamel, M. ;Revel-Vilk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

## Abstract ## Objective Few studies have addressed antiphospholipid syndrome (APS) among children. Our aims were to analyze the clinical and laboratory manifestations in a pediatric APS cohort and to assess the influence of inherited thrombophilia factors on the outcome of children with APS. ##

Aspirin for primary thrombosis preventio
✍ Doruk Erkan; Melanie J. Harrison; Roger Levy; Margaret Peterson; Michelle Petri; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Objective To determine the efficacy of a daily dose of 81 mg aspirin in primary thrombosis prevention in asymptomatic, persistently antiphospholipid antibody (aPL)–positive individuals (those with positive aPL but no vascular and/or pregnancy events). ## Methods The Antiphospholip